News

The brain is the last great frontier - Joris de Wit
15 June 2013
“When I was fourteen, I already knew I wanted to be a scientist. I was fascinated with biology and how things work. The brain is the last great frontier,” says Joris de Wit.
Exploring the process of physiological brain aging
15 June 2013
Aging is a risk factor for several neurodegenerative diseases. Little is known about the process of physiological brain aging in the absence of neurodegeneration.
25-31 August, 2013 - RNA and the Etiology of Brain Disease - Cortona, Italy
5 June 2013
The IBRO-Kemali College on “RNA and the Etiology of Brain Disease” will be held at the Neuroscience School of Advanced Studies from August 25th until August 31st, 2013.
Janssen, J&J Innovation, VIB, KU Leuven and UZ Leuven join forces to combat neurological diseases
29 May 2013
Janssen and Johnson & Johnson Innovation are launching Stellar. This project will overcome the inefficiencies in translating basic molecular insights to diagnostics and therapeutics for neurodegenerative diseases.
A new strategy required in the search for Alzheimer's drugs?
24 May 2013
Alessia Soldano and Bassem Hassan (VIB/KU Leuven) were the first to unravel the function of APPL – the fruit-fly version of APP – in the brain of healthy fruit flies.
Faulty energy production in brain cells leads to disorders ranging from Parkinson’s to intellectual disability
16 May 2013
Neuroscientist Patrik Verstreken of VIB (Flanders Institute for Biotechnology) and KU Leuven has shown for the first time that dysfunctional mitochondria in brain cells can lead to learning disabilities.
Fruit flies can help us for the development of improved anesthetics
20 March 2013
General anesthetic result in a loss of consciousness and insensitivity to pain, apparently in the same manner in all animals, from invertebrates to humans.
Prevention is better than cure. Also for Alzheimer’s disease!
1 February 2013
On Monday 4 February, Dennis J. Selkoe and five other “brain teasers” will receive an honorary doctorate from the KU Leuven.
LRRK2 control of synapse - a delicate balancing exercise
14 December 2012
Until now, it was not clearly understood how LRRK2 regulated synaptic function necessary in the treatment of Parkinson’s. This situation has now been remedied by Samer Matta from the Bart De Strooper lab, in collaboration with the Patrik Verstreken lab.
NERF - where biotech and micro-electronics meet
14 December 2012
In 2009 IMEC, KU Leuven and VIB set up a joint basic research initiative Neuro-Electronics Research Flanders (NERF) whose main mission is to unravel the function of brain circuits.
Leuven research opens new pathway for the treatment of Alzheimer’s disease
2 December 2012
Scientists from VIB and KU Leuven have discovered a new target molecule for the development of a treatment against Alzheimer’s disease.
Researchers studying hereditary illnesses of peripheral nervous system make important discovery
10 September 2012
Antwerp researchers (VIB/University of Antwerp) were the first to discover that mutations in the HINT1 gene are linked to a specific type of peripheral neuropathy.
Too much protein HUWE1 causes intellectual disability
31 August 2012
2 to 3 % of the children are born with an intellectual disability. VIB researchers at KU Leuven show that increased production of the HUWE1 protein is the cause in some patients.
Zebra fish point the way towards new therapies for amyotrophic lateral sclerosis
27 August 2012
Leuven scientists (VIB/KU Leuven) are using zebrafish as a model in their search for genes that play a role in the mechanism of amyotrophic lateral sclerosis (ALS).
Christine Van Broeckhoven given prestigious MetLife award for medical research worth $ 250,000
15 May 2012
On Tuesday, May 15, in New York, the MetLife Foundation handed its annual Award for Medical Research to Christine Van Broeckhoven, of VIB and Universiteit Antwerpen, for her pioneering research on Alzheimer's disease and related disorders.

1 2 3 4 5 Next»

Get news updates:

Email updates
RSS